Biotech Values

[Double_Bagel]

Northwest Biotherapeutics and CREW attack Adam Feurestein

http://www.washingtonpost.com/business/northwest-biotherapeutics-stock-woes-highlight-the-harm-of-short-sales/2014/09/26/78b99b0a-4507-11e4-b47c-f5889e061e5f_story.html

Northwest Biotherapeutics stock woes highlight the harm of short sales

In late July, CREW’s (A nonprofit advocacy group -- Citizens for Responsibility and Ethics in Washington) executive director, Melanie Sloan, asked the Securities and Exchange Commission to investigate market manipulation of Northwest Bio’s stock. (Sloan told me her organization has never been contacted by the company and has no connection to its executives, investors or directors.)

In her letter, Sloan called particular attention to Adam Feuerstein, a biotech reporter whose relentlessly negative blog posts for thestreet.com this year have not only been filled with exaggeration, mischaracterization and half-truths, but curiously have also coincided with the spikes in short trading.